Sulfonamides and their isosters as carbonic anhydrase inhibitors

被引:0
|
作者
Carta, Fabrizio [1 ]
Supuran, Claudiu T. [1 ,2 ]
Scozzafava, Andrea [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Univ Florence, NEUROFARBA Dept, Sect Pharmaceut Chem, I-50019 Florence, Italy
关键词
RAY CRYSTAL-STRUCTURES; ISOZYME-II; WATER-MOLECULES; DRUG DISCOVERY; TOPIRAMATE; PATENT; EXPRESSION; XII; ACETAZOLAMIDE; DIURETICS;
D O I
10.4155/FMC.14.68
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Molecules containing the sulfonamide group (R-SO2NH2) as well as its structurally related isosters, sulfamido (R-NH-SO2NH2) and sulfamato (R-O-SO2NH2), constitute the most important class of inhibitors acting on the metalloenzyme carbonic anhydrase (EC 4.2.1.1). Despite their presence in the literature, in general the reports lack of a clear and organic overview linking the main structural features of the clinically used inhibitors with the therapeutic aspects. The current review is intended to highlight the structural basis of the interactions of sulfonamide-like groups within the active site of the carbonic anhydrases and will summarize the clinical use of the most interesting molecules for the treatment of relevant pathologies, such as glaucoma, obesity, cancer and CNS-affecting diseases.
引用
收藏
页码:1149 / 1165
页数:17
相关论文
共 50 条
  • [1] Carbonic anhydrase inhibitors
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3467 - 3474
  • [2] Chromone containing sulfonamides as potent carbonic anhydrase inhibitors
    Ekinci, Deniz
    al-Rashida, Mariya
    Abbas, Ghulam
    Senturk, Murat
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (05) : 744 - 747
  • [3] Five-Membered Heterocyclic Sulfonamides as Carbonic Anhydrase Inhibitors
    Angeli, Andrea
    Paoletti, Niccolo
    Supuran, Claudiu T.
    MOLECULES, 2023, 28 (07):
  • [4] Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII
    Rami, Marouan
    Maresca, Alfonso
    Smaine, Fatma-Zhora
    Montero, Jean-Louis
    Scozzafava, Andrea
    Winum, Jean-Yves
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (10) : 2975 - 2979
  • [5] An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
    Supuran, Claudiu T.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (04) : 297 - 307
  • [6] Development of sulfonamides incorporating phenylacrylamido functionalities as carbonic anhydrase isoforms I, II, IX and XII inhibitors
    Angapelly, Srinivas
    Ramya, P. V. Sri
    Angeli, Andrea
    Del Prete, Sonia
    Capasso, Clemente
    Arifuddin, Mohammed
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (20) : 5726 - 5732
  • [7] Emerging role of carbonic anhydrase inhibitors
    Supuran, Claudiu T.
    CLINICAL SCIENCE, 2021, 135 (10) : 1233 - 1249
  • [8] Polypharmacology of carbonic anhydrase inhibitors and activators
    Bonardi, Alessandro
    Supuran, Claudiu T.
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (05) : 567 - 580
  • [9] Carbonic anhydrase inhibitors: Thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
    Innocenti, Alessio
    Maresca, Alfonso
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3938 - 3941
  • [10] Drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors
    Supuran, Claudiu T.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (04) : 423 - 431